Form 8-K - Current report:
SEC Accession No. 0001193125-23-164462
Filing Date
2023-06-09
Accepted
2023-06-09 16:15:33
Documents
12
Period of Report
2023-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d510560d8k.htm   iXBRL 8-K 32464
  Complete submission text file 0001193125-23-164462.txt   157304

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA annx-20230608.xsd EX-101.SCH 2847
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20230608_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20230608_pre.xml EX-101.PRE 11708
6 EXTRACTED XBRL INSTANCE DOCUMENT d510560d8k_htm.xml XML 3469
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 231005459
SIC: 2834 Pharmaceutical Preparations